OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane
Nicoletta Bertorello, Roberto Luksch, Gianni Bisogno, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 9
Closed Access | Times Cited: 7
Nicoletta Bertorello, Roberto Luksch, Gianni Bisogno, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 9
Closed Access | Times Cited: 7
Showing 7 citing articles:
Natural Products for Preventing and Managing Anthracycline-Induced Cardiotoxicity: A Comprehensive Review
Jarosław Szponar, Przemysław Niziński, Jarosław Dudka, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1151-1151
Open Access | Times Cited: 5
Jarosław Szponar, Przemysław Niziński, Jarosław Dudka, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1151-1151
Open Access | Times Cited: 5
Pediatric Urologic Oncology Series - Late Effects after Treatment for Wilms Tumor and Other Pediatric Renal Neoplasms
Kathleen Kieran, Margarett Shnorhavorian
Urology (2025)
Closed Access
Kathleen Kieran, Margarett Shnorhavorian
Urology (2025)
Closed Access
The Daunomycin: Biosynthesis, Actions, and the Search for New Solutions to Enhance Production
Baveesh Pudhuvai, K. Beneš, Vladislav Čurn, et al.
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2639-2639
Open Access | Times Cited: 2
Baveesh Pudhuvai, K. Beneš, Vladislav Čurn, et al.
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2639-2639
Open Access | Times Cited: 2
Cancer survivors and cardiovascular diseases: from preventive strategies to treatment
Daniela Di Lisi, Cristina Madaudo, Francesca Macaione, et al.
Journal of Cardiovascular Medicine (2024)
Closed Access
Daniela Di Lisi, Cristina Madaudo, Francesca Macaione, et al.
Journal of Cardiovascular Medicine (2024)
Closed Access
Safety Evaluation of the Combination with Dexrazoxane and Anthracyclines: A Disproportionality Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database
Danyi Liu, Junting Liu, Rui Xiao, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1739-1739
Open Access
Danyi Liu, Junting Liu, Rui Xiao, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1739-1739
Open Access
Comment on: Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane
Annelies M. C. Mavinkurve‐Groothuis, Esmée C. de Baat, Elizabeth A. M. Feijen, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 10
Open Access | Times Cited: 1
Annelies M. C. Mavinkurve‐Groothuis, Esmée C. de Baat, Elizabeth A. M. Feijen, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 10
Open Access | Times Cited: 1
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers
Daniela Di Lisi, Christian Cadeddu Dessalvi, Concetta Zito, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 3, pp. 102229-102229
Open Access | Times Cited: 1
Daniela Di Lisi, Christian Cadeddu Dessalvi, Concetta Zito, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 3, pp. 102229-102229
Open Access | Times Cited: 1
